The principles of quantitative structure-activity relationships (QSAR) are based on the premise that the properties of a chemical are implicit in its molecular structure. Therefore, if a mechanistic .hypothesis can be proposed linking a group of related chemicals with a particular toxic end point, the hypo.hesis can be used to define relevant parameters to establish a QSAR. Ways in which OSAR and in vitro toxicology can complement each other in development of alternatives to live animal experiments are described and illustrated by examples from acute toxicological end points. Integration of QSAR and in vitro methods is examined in the context of assessing mechanistic competence and improving the design of in vitro assays and the development of prediction models. The nature of biological variability is explored together with its implications for the selection of sets of chemicals for test development, optimization, and validation. Methods are described to support the use of data from in vivo tests that do not meet today's stringent requirements of acceptability. Integration of QSAR and in vitro methods into strategic approaches for the replacement, reduction, and refinement of the use of animals is described with examples.
Introduction
The principles of quantitative structureactivity relationships (QSAR) are based on the premise that the properties of a chemical are implicit in its molecular structure. Therefore, if a mechanistic hypothesis can be proposed linking a group of related chemicals with a particular toxic end point, the hypothesis is used to define relevant parameters to establish a structure-activity relationship. The resulting model is then tested and the hypothesis and parameters refined until an adequate model is obtained. These principles have been successfully applied in this laboratory to predict a skin permeability coefficients (1), the skin corrosivity of organic acids, bases, phenols (2, 3) and electrophilic organic chemicals (4) , and the eye irritation potential of neutral organic chemicals (5, 6) .
For a QSAR to be valid and reliable, the dependent property for all the chemicals covered by the relationship must be elicited by a mechanism that is both common and relevant to that dependent property. Attempts to derive QSARs for data sets in which either the dependent property is derived by more than one mechanism or the mechanism of action is wrongly defined do not usually lead to robust models.
The same principles that are applied to the development of QSARs must also be applied to the development of in vitro alternatives to animal tests if those methods are to be reliable. These principles have been overlooked in many cases, particularly in the prediction of acute toxic effects, with inevitable results. Some alternative tests determine end points that are substantially different from those that they claim to predict because the mechanism modeled by the in vitro alternative represents only part of that which is active in vivo. In other cases, tests have been developed that can predict end points accurately for some classes of chemicals but are then wrongly assumed to be applicable to all chemical classes. The fact that different types of chemicals may elicit changes in a particular biological end point through different mechanisms clearly has not been appreciated.
This paper describes some of the ways in which QSAR and in vitro toxicology can complement each other in the development of alternatives to live animal experiments by using examples from acute toxicological end points. The mechanistic approach to QSAR and in vitro methods is examined in the context of assessing the mechanistic competence, improving the design of in vitro assays, and developing prediction models. (13) .
This third method has been demonstrated using the principal components map for the eye irritation potential of neutral organic chemicals (5) . Using the principal components map allows selection of chemicals that cover the widest possible parameter space in terms of both biological activity and physicochemical properties. For example, this may be achieved by selecting a series of chemicals that would start in an area predicted to be nonirritant, pass through the irritant area, and move out again into the nonirritant area. This is illustrated by track "a" in Figure 1A . The same principal components map can also be used to identify regions of parameter space incompletely covered by the current database (e.g., in the region marked "b" in Figure IA ). Obtaining biological test data from chemicals in these regions would be essential for the completeness of the nonanimal model. Similarly, the map can be used to identify regions of parameter Environmental Health Perspectives * Vol 106, Supplement 2 * April 1998 In a recent QSAR study of the eye irritation potential of neutral organic chemicals (6), a relationship was established between the eye irritation data of the European Centre for Ecotoxicology and Toxicology of Chemicals (ECETOC) data bank (23) (and EC classifications derived from those data) and a large body of historical eye irritation data assessed by the criteria of Carpenter and Smyth (24) ; the utility of the latter data for use in nonanimal alternatives is therefore increased.
Integrated Approaches
One of the strengths of QSAR is the ease with which it can model partition either directly, e.g., logP, or through a combination of parameters, as exemplified by the modeling of skin permeability (1, 25 in QSARs. An example of this approach currently under development is the use of neutral red uptake data to measure the cytotoxicity of electrophilic organic acids. These data combined with parameters used in a previous QSAR study of the corrosivity of organic acids (2) are proving useful in discriminating between chemicals with the EC dassifications R34 (corrosive, causes burns) and R35 (corrosive, causes severe burns) (26) .
An even more important contribution for QSAR is to play a role in integrated strategies that lead to a reduction in the use of experimental animals. Two examples of proposed strategies are described briefly.
A scheme illustrating the strategic approach to skin sensitization hazard identification is illustrated in Figure 3 (27) . In the first instance, a substance of defined chemical structure to be investigated is entered into the DEREK (deduction of risk from existing knowledge) expert system (28, 29) to determine if it contains a structural alert a fragment of chemical structure that could lead to the reactivity component of skin sensitization (30) . If no structural alert is identified, the chemical is not likely to be a significant skin sensitizer; however, this should be confirmed using a standard animal assay-the mouse local lymph node assay (LLNA) (31) is considered most appropriate. If a skin sensitization structural alert is identified, the chemical has met the first of the two criteria for classification.
To be classified as a skin sensitizer, a chemical must be able not only to react chemically with skin protein either directly or after appropriate metabolism but also to partition into the relevant skin compartment. Skin permeability is assessed using a QSAR model (1) . If the skin penetration of the chemical is sufficiently high, the chemical is assumed also to have significant skin sensitization potential and can be classified and labeled accordingly. If assay, it should be classified a skin sensitizer and labeled accordingly (32) . When the result clearly does not meet the criteria for classification, then in our view no further work should be necessary. The chemical may be regarded as having insufficient sensitization potential to merit classification and labeling as a skin sensitizer. This proposed strategy provides an important opportunity for both substantial reduction and refinement of animal usage in a manner that does not compromise the existing standards of classification and labeling of skin sensitization hazard in the European Union
The second strategy for identifying and classifying chemicals causing skin irritation or corrosivity uses a combination of QSAR and in vitro methods (33 (34) , peroxisome proliferation (35) , and teratogenicity (36) , may be similarly amenable to these approaches.
Ultimately, QSAR models have the potential to be used reliably to predict toxicity of chemicals and thus replace animals in some toxicity studies. In the meantime, QSAR methods can be used to * evaluate the mechanistic competence of in vitro methods * refine existing in vitro methods and give insight into the design of new ones * reduce the need for testing and hence reduce the number of animals used * provide balanced selections of chemicals for use in the validation of in vitro tests * check the acceptability and consistency of biological data for use in the development and validation of alternative methods * play a role in integrated strategies along with both in vitro and in vivo tests and eventually lead to a reduction in the use of experimental animals.
